Gastric schwannoma with adjacent external progression harbored aberrant nf2 gene

Digestive Endoscopy

Volumn 21, Issue 3, 2009, Pages 192-195

  Ogasawara, Naotaka ^a   Sasaki, Makoto ^a   Ishiguro, Hideyuki ^a   Itoh, Yukimi ^a   Nojiri, Syunsuke ^a   Kubota, Eiji ^a   Wada, Tsuneya ^a   Kataoka, Hiromi ^a   Kuwabara, Yoshiyuki ^a   Joh, Talkashi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Gastric mutation; Neurofibromatosis 2; Schwannoma

Indexed keywords

CD34 ANTIGEN; PROTEIN S 100;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ELECTROGASTROGRAPHY; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEURILEMOMA; NEUROFIBROMATOSIS; NF2 GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; POINT MUTATION; SPINDLE CELL CARCINOMA; STOMACH TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; NEURILEMMOMA; NEUROFIBROMATOSIS 2; STOMACH NEOPLASMS;

EID: 67949086755     PISSN: 09155635     EISSN: 14431661     Source Type: Journal    
DOI: 10.1111/j.1443-1661.2009.00885.x     Document Type: Article

References (10)

1. Rouleau GA, Merel P, Lutchman M et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 1993; 363:515-21.
2. Colman SD, Williams CA, Wallace MR. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NFl gene. Nat. Genet. 1995; 11: 90-2.
3. Toliat MR, Erdogan F, Gewies A et al. Analysis of the NF1 gene by temperature gradient gel electrophoresis reveals a high incidence of mutations in exon 4b. Electrophoresis 2000; 21:541-4.
4. Lasota J, Wasag B, Dansonka-Mieszkowska A et al. Evaluation of NF2 and NF1 tumor suppressor genes in distinctive gastrointestinal nerve sheath tumors traditionally diagnosed as benign schwannomas: A study of 20 cases. Lab. Invest. 2003; 83:1361-71.
5. Merel P, Hoang-Xuan K, Sanson M et al. Screening for germ-line mutations in the NF2 gene. Genes Chromosomes Cancer 1995; 12:117-27.
6. Prevot S, Bienvenu L, Vaillant JC, de Saint-Maur PP. Benign schwannoma of the digestive tract: A clinicopathologic and immunohistochemical study of five cases, including a case of esophageal tumor. Am. J. Surg. Pathol. 1999; 23: 431-6.
7. Ramboer K, Moons P, De Breuck Y, Van Hoe L, Baert AL. Benign mesenteric schwannoma: MRI findings. J. Beige. Radiol. 1998; 81:3-4.
8. Sekido Y, Pass HI, Bader S et al. Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res. 1995; 55:1227-31.
9. Yunoue S, Tokuo H, Fukunaga K et al. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. J. Biol. Chem. 2003; 278: 26 958-69.
10. Fukasawa T, Chong JM, Sakurai S et al. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor. Jpn. J. Cancer Res. 2000; 91:1241-9.